ReFRAME Related Library
Ref. TM-L9230
| 1mg | To inquire | |
| 30µl*10 (DMSO) | To inquire | |
| 50µl*10 (DMSO) | To inquire | |
| 100µl*10 (DMSO) | To inquire | |
| 250µl*10 (DMSO) | To inquire |
Product Information
A unique collection of 3210 compounds for high-throughput screening and high-content screening, an effective tool for drug repurposing and anti-COVID-19 drug development
- Some compounds have been marketed and approved by FDA, EMA, NMPA and other authorities, and most have passed Phase I clinical studies
- ReFRAME Related Library has excellent structural diversity through cluster analysis of structural diversity, including 2698 clusters (similarity between different clusters <70%), with an average of 1.2 compounds per cluster.
- Covering multiple research areas: oncology, cardiovascular drugs, anti-inflammatory/immune, neurological drugs, respiratory drugs, etc.
- Diverse targets, including 5-HT Receptor, Sodium Channel, p38 MAPK, PI3K, MEK, etc.
- Detailed specifications, compound structure, target information, disease indication information, activity description, etc.
- NMR, HPLC/LCMS and other detection techniques to ensure correct structure and high purity of the product and reduce false positives.
Chemical properties
Technical inquiry about: TM-L9230 ReFRAME Related Library
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
